{
  "PMAX": {
    "ticker": "PMAX",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2025-01-15T21:01:23Z",
        "headline": "Powell Max Announced Acquisition Plans Targeting $1.5M-$5M Revenue Firms To Expand In Hong Kong And Asia Financial Communications Market",
        "id": 43014913,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "PMAX"
        ],
        "updated_at": "2025-01-15T21:01:24Z",
        "url": "https://www.benzinga.com/m-a/25/01/43014913/powell-max-announced-acquisition-plans-targeting-1-5m-5m-revenue-firms-to-expand-in-hong-kong-and-as",
        "added_at": "2025-01-16T07:53:03.855Z"
      }
    ],
    "hod": false,
    "float": "2.59M",
    "price": "3",
    "time": "01:57:07",
    "isActive": true,
    "firstSeen": "2025-01-16T07:53:02.882Z",
    "lastSeen": "2025-01-16T13:09:11.269Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 3140,
      "Avg. Daily Volume": "N/A",
      "Short Float": 36660,
      "Short Ratio": "N/A"
    }
  },
  "SLXN": {
    "ticker": "SLXN",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2025-01-15T21:02:00Z",
        "headline": "Silexion Therapeutics Reports Additional Preclinical Data For SIL-204, Demonstrating Synergy With First-Line Pancreatic Cancer Chemotherapies",
        "id": 43014935,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "SLXN"
        ],
        "updated_at": "2025-01-15T21:06:35Z",
        "url": "https://www.benzinga.com/general/biotech/25/01/43014935/silexion-therapeutics-reports-additional-preclinical-data-for-sil-204-demonstrating-impressive-sy",
        "added_at": "2025-01-16T07:53:03.967Z"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2025-01-16T07:59:40Z",
        "headline": "Reported Earlier, Silexion Therapeutics Prices Public Offering Of 3,703,703 Shares And Warrants At $1.35, Raising $5M",
        "id": 43021362,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "SLXN"
        ],
        "updated_at": "2025-01-16T07:59:40Z",
        "url": "https://www.benzinga.com/news/25/01/43021362/reported-earlier-silexion-therapeutics-prices-public-offering-of-3-703-703-shares-and-warrants-at-1",
        "added_at": "2025-01-16T08:03:53.209Z"
      }
    ],
    "hod": true,
    "float": "1.04M",
    "price": "2.9",
    "time": "01:56:40",
    "isActive": true,
    "firstSeen": "2025-01-16T07:53:02.883Z",
    "lastSeen": "2025-01-16T09:00:21.165Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 38190,
      "Avg. Daily Volume": 1020000,
      "Short Float": 880440,
      "Short Ratio": "3.74%"
    }
  },
  "BKYI": {
    "ticker": "BKYI",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2025-01-15T13:11:06Z",
        "headline": "National Bank Of Egypt Is Deploying BIO-key's PortalGuard Platform",
        "id": 43000352,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "BKYI"
        ],
        "updated_at": "2025-01-15T13:11:06Z",
        "url": "https://www.benzinga.com/news/25/01/43000352/national-bank-of-egypt-is-deploying-bio-keys-portalguard-platform",
        "added_at": "2025-01-16T07:53:04.078Z"
      }
    ],
    "hod": false,
    "float": "2.33M",
    "price": "2.33",
    "time": "01:55:07",
    "isActive": true,
    "firstSeen": "2025-01-16T07:53:02.883Z",
    "lastSeen": "2025-01-16T12:00:47.966Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 300420,
      "Avg. Daily Volume": 2330000,
      "Short Float": 2240000,
      "Short Ratio": "12.89%"
    }
  },
  "AMPG": {
    "ticker": "AMPG",
    "news": [],
    "hod": false,
    "float": "16.63M",
    "price": "2.27",
    "time": "01:49:25",
    "isActive": true,
    "firstSeen": "2025-01-16T07:53:02.883Z",
    "lastSeen": "2025-01-16T09:00:21.177Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 896400,
      "Avg. Daily Volume": 14910000,
      "Short Float": 7000000,
      "Short Ratio": "6.01%"
    }
  },
  "QSI": {
    "ticker": "QSI",
    "news": [
      {
        "author": "Benzinga Insights",
        "content": "",
        "created_at": "2025-01-15T15:30:26Z",
        "headline": "(QSI) - Analyzing Quantum-Si's Short Interest",
        "id": 43006669,
        "images": [
          {
            "size": "large",
            "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2023/movers_image_1.jpeg"
          },
          {
            "size": "small",
            "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/movers_image_1.jpeg"
          },
          {
            "size": "thumb",
            "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2023/movers_image_1.jpeg"
          }
        ],
        "source": "benzinga",
        "summary": " ",
        "symbols": [
          "QSI"
        ],
        "updated_at": "2025-01-15T15:30:27Z",
        "url": "https://www.benzinga.com/insights/short-sellers/25/01/43006669/qsi-analyzing-quantum-sis-short-interest",
        "added_at": "2025-01-16T07:53:04.299Z"
      }
    ],
    "hod": false,
    "float": "109.95M",
    "price": "2.6",
    "time": "01:26:07",
    "isActive": true,
    "firstSeen": "2025-01-16T07:53:02.893Z",
    "lastSeen": "2025-01-16T09:05:28.420Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 23650000,
      "Avg. Daily Volume": 109950000,
      "Short Float": 18400000,
      "Short Ratio": "21.51%"
    }
  },
  "RZLV": {
    "ticker": "RZLV",
    "news": [],
    "hod": false,
    "float": "46.37M",
    "price": "2.74",
    "time": "10:01:09",
    "isActive": true,
    "firstSeen": "2025-01-16T09:01:33.378Z",
    "lastSeen": "2025-01-16T09:11:17.206Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 3870000,
      "Avg. Daily Volume": 46370000,
      "Short Float": 6850000,
      "Short Ratio": "8.35%"
    }
  },
  "SOBR": {
    "ticker": "SOBR",
    "news": [],
    "hod": false,
    "float": "689.04K",
    "price": "1.79",
    "time": "10:01:08",
    "isActive": true,
    "firstSeen": "2025-01-16T09:01:33.379Z",
    "lastSeen": "2025-01-16T13:07:48.873Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 673230,
      "Avg. Daily Volume": 690000,
      "Short Float": 1780000,
      "Short Ratio": "97.57%"
    }
  },
  "KITT": {
    "ticker": "KITT",
    "news": [],
    "hod": false,
    "float": "5.56M",
    "price": "3.22",
    "time": "10:00:53",
    "isActive": true,
    "firstSeen": "2025-01-16T09:01:33.379Z",
    "lastSeen": "2025-01-16T09:14:08.819Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 943770,
      "Avg. Daily Volume": 5580000,
      "Short Float": 1760000,
      "Short Ratio": "16.91%"
    }
  },
  "VRME": {
    "ticker": "VRME",
    "news": [],
    "hod": false,
    "float": "8.11M",
    "price": "4.37",
    "time": "10:01:51",
    "isActive": true,
    "firstSeen": "2025-01-16T09:02:29.163Z",
    "lastSeen": "2025-01-16T09:02:29.163Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 7900,
      "Avg. Daily Volume": 8109999.999999999,
      "Short Float": 1590000,
      "Short Ratio": "0.10%"
    }
  },
  "WHLR": {
    "ticker": "WHLR",
    "news": [],
    "hod": false,
    "float": "2.40M",
    "price": "4.81",
    "time": "10:02:46",
    "isActive": true,
    "firstSeen": "2025-01-16T09:03:16.742Z",
    "lastSeen": "2025-01-16T13:25:44.052Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 178470,
      "Avg. Daily Volume": 1310000,
      "Short Float": 675040,
      "Short Ratio": "13.62%"
    }
  },
  "QUBT": {
    "ticker": "QUBT",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2025-01-15T13:34:27Z",
        "headline": "Quantum Computing Collaborates With Sanders Tri-Institutional Therapeutics Discovery Institute To Support Research Using Dirac-3 Systems",
        "id": 43001253,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "QUBT"
        ],
        "updated_at": "2025-01-15T13:34:28Z",
        "url": "https://www.benzinga.com/news/25/01/43001253/quantum-computing-collaborates-with-sanders-tri-institutional-therapeutics-discovery-institute-to-su",
        "added_at": "2025-01-16T09:04:10.257Z"
      }
    ],
    "hod": false,
    "float": "101.12M",
    "price": "13.36",
    "time": "10:03:37",
    "isActive": true,
    "firstSeen": "2025-01-16T09:04:08.349Z",
    "lastSeen": "2025-01-16T09:08:37.365Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 16070000,
      "Avg. Daily Volume": 101120000,
      "Short Float": 36830000,
      "Short Ratio": "15.90%"
    }
  },
  "INTZ": {
    "ticker": "INTZ",
    "news": [],
    "hod": false,
    "float": "13.02M",
    "price": "3.23",
    "time": "10:07:11",
    "isActive": true,
    "firstSeen": "2025-01-16T09:07:23.301Z",
    "lastSeen": "2025-01-16T09:37:43.510Z",
    "filings": [
      {
        "formType": "S-3/A",
        "description": "[Amend] Registration statement under Securities Act of 1933\nAcc-no: 0001683168-24-008792 (33 Act)  Size: 988 KB",
        "date": "2024-12-17"
      },
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001683168-24-005726 (33 Act)  Size: 1 MB",
        "date": "2024-08-15"
      }
    ],
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 3240000,
      "Avg. Daily Volume": 13020000,
      "Short Float": 5560000,
      "Short Ratio": "24.91%"
    }
  },
  "DOYU": {
    "ticker": "DOYU",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2025-01-16T09:14:45Z",
        "headline": "DouYu International Tapped Ms. Simin Ren As Co-CEO, Effective Today",
        "id": 43021948,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "DOYU"
        ],
        "updated_at": "2025-01-16T09:14:45Z",
        "url": "https://www.benzinga.com/news/25/01/43021948/douyu-international-tapped-ms-simin-ren-as-co-ceo-effective-today",
        "added_at": "2025-01-16T09:19:24.832Z"
      },
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2025-01-16T09:13:22Z",
        "headline": "DouYu International Board Approved A Special Cash Dividend Of $9.94/ADS",
        "id": 43021943,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "DOYU"
        ],
        "updated_at": "2025-01-16T09:13:22Z",
        "url": "https://www.benzinga.com/news/25/01/43021943/douyu-international-board-approved-a-special-cash-dividend-of-9-94ads",
        "added_at": "2025-01-16T09:19:24.833Z"
      }
    ],
    "hod": false,
    "float": "31.63M",
    "price": "16.74",
    "time": "10:19:01",
    "isActive": true,
    "firstSeen": "2025-01-16T09:19:22.706Z",
    "lastSeen": "2025-01-16T12:24:42.891Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 712320,
      "Avg. Daily Volume": 31630000,
      "Short Float": 131480,
      "Short Ratio": "2.25%"
    }
  },
  "OTLK": {
    "ticker": "OTLK",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2025-01-16T11:04:30Z",
        "headline": "Outlook Therapeutics Completed The Analysis Of The Complete 12-Week Safety And Efficacy Results For NORSE EIGHT Trial Of ONS-5010 In Wet Age-related Macular Degeneration Patients, Demonstrating Noninferiority To Ranibizumab, Plans To Resubmit The Biologics License Application In Q1 Of Calendar 2025.",
        "id": 43023087,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "OTLK"
        ],
        "updated_at": "2025-01-16T11:04:31Z",
        "url": "https://www.benzinga.com/general/biotech/25/01/43023087/outlook-therapeutics-completed-the-analysis-of-the-complete-12-week-safety-and-efficacy-results-f",
        "added_at": "2025-01-16T11:08:53.505Z"
      }
    ],
    "hod": false,
    "float": "16.48M",
    "price": "2.8",
    "time": "12:02:43",
    "isActive": true,
    "firstSeen": "2025-01-16T11:02:47.288Z",
    "lastSeen": "2025-01-16T11:03:25.356Z",
    "filings": [
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001104659-24-052965 (33 Act)  Size: 229 KB",
        "date": "2024-04-26"
      }
    ],
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 2890000,
      "Avg. Daily Volume": 16040000,
      "Short Float": 1760000,
      "Short Ratio": "18.02%"
    }
  },
  "ZENA": {
    "ticker": "ZENA",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2025-01-16T12:32:16Z",
        "headline": "ZenaTech Completes Acquisition Of Weddle Surveying Inc.",
        "id": 43025275,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "ZENA"
        ],
        "updated_at": "2025-01-16T12:32:16Z",
        "url": "https://www.benzinga.com/m-a/25/01/43025275/zenatech-completes-acquisition-of-weddle-surveying-inc",
        "added_at": "2025-01-16T12:34:13.940Z"
      }
    ],
    "hod": false,
    "float": "6.60M",
    "price": "7.08",
    "time": "13:30:41",
    "isActive": true,
    "firstSeen": "2025-01-16T12:30:44.028Z",
    "lastSeen": "2025-01-16T12:31:40.331Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 454430,
      "Avg. Daily Volume": "N/A",
      "Short Float": 6210000,
      "Short Ratio": "N/A"
    }
  },
  "XXII": {
    "ticker": "XXII",
    "news": [],
    "hod": false,
    "float": "501.79K",
    "price": "8.29",
    "time": "13:55:22",
    "isActive": true,
    "firstSeen": "2025-01-16T12:55:31.190Z",
    "lastSeen": "2025-01-16T12:55:31.190Z",
    "filings": [
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001104659-24-113547 (33 Act)  Size: 298 KB",
        "date": "2024-11-01"
      },
      {
        "formType": "S-3",
        "description": "Registration statement under Securities Act of 1933\nAcc-no: 0001104659-24-100290 (33 Act)  Size: 227 KB",
        "date": "2024-09-16"
      }
    ],
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 91480,
      "Avg. Daily Volume": 470000,
      "Short Float": 77120,
      "Short Ratio": "19.46%"
    }
  },
  "PALI": {
    "ticker": "PALI",
    "news": [
      {
        "author": "Benzinga Newsdesk",
        "content": "",
        "created_at": "2025-01-16T13:05:03Z",
        "headline": "Palisade Bio Completes All Five Single Ascending Dose Cohorts And Commences Multiple Ascending Dose Cohorts In Phase 1a/b Trial Of PALI-2108 For Ulcerative Colitis; Co. On Track To Report Topline Data In 1H 2025",
        "id": 43026095,
        "images": [],
        "source": "benzinga",
        "summary": "",
        "symbols": [
          "PALI"
        ],
        "updated_at": "2025-01-16T13:05:04Z",
        "url": "https://www.benzinga.com/general/biotech/25/01/43026095/palisade-bio-completes-all-five-single-ascending-dose-cohorts-and-commences-multiple-ascending-do",
        "added_at": "2025-01-16T13:08:54.369Z"
      }
    ],
    "hod": false,
    "float": "2.74M",
    "price": "1.95",
    "time": "14:01:24",
    "isActive": true,
    "firstSeen": "2025-01-16T13:02:45.943Z",
    "lastSeen": "2025-01-16T13:27:10.782Z",
    "shorts": {
      "Settlement Date": "Dec 31, 2024",
      "Short Interest": 66280,
      "Avg. Daily Volume": 2720000,
      "Short Float": 1250000,
      "Short Ratio": "2.44%"
    }
  }
}